BEAM THERAPEUTICS INC.
27.35
08-November-24 14:44:09
15 minutes delayed
Stocks
+1.25
+4.79%
Today's range
25.68 - 27.38
ISIN
N/A
Source
NASDAQ
-
31 Oct 2023 05:00:00 By Nasdaq GlobeNewswire
-
07 Sep 2023 09:00:00 By Nasdaq GlobeNewswire
-
05 Sep 2023 05:30:00 By Nasdaq GlobeNewswire
-
Beam Therapeutics to Participate in Upcoming September Investor Conferences
31 Aug 2023 05:30:00 By Nasdaq GlobeNewswire
-
Beam Therapeutics Reports Pipeline Updates and Second Quarter 2023 Financial Results
08 Aug 2023 05:30:00 By Nasdaq GlobeNewswire
-
Beam Therapeutics to Participate in Upcoming May Investor Conferences
17 May 2023 05:30:00 By Nasdaq GlobeNewswire
-
Beam Therapeutics to Participate in RBC Capital Markets 2023 Global Healthcare Conference
11 May 2023 05:30:00 By Nasdaq GlobeNewswire
-
Beam Therapeutics Reports Pipeline Updates and First Quarter 2023 Financial Results
10 May 2023 05:30:00 By Nasdaq GlobeNewswire
-
Beam Therapeutics to Participate in the Guggenheim 2023 Genomic Medicines and Rare Disease Day
27 Mar 2023 06:30:00 By Nasdaq GlobeNewswire
-
Beam Therapeutics Appoints Gopi Shanker, Ph.D., as Chief Scientific Officer
21 Mar 2023 05:30:00 By Nasdaq GlobeNewswire
-
Beam Therapeutics to Participate in the Barclays 2023 Global Healthcare Conference
15 Mar 2023 05:30:00 By Nasdaq GlobeNewswire
-
Beam Therapeutics to Participate in the 43rd Annual Cowen Healthcare Conference
01 Mar 2023 05:30:00 By Nasdaq GlobeNewswire
-
28 Feb 2023 05:30:00 By Nasdaq GlobeNewswire
-
Beam Therapeutics to Participate in the SVB Securities Virtual Global Biopharma Conference
07 Feb 2023 05:30:00 By Nasdaq GlobeNewswire
-
09 Jan 2023 05:30:00 By Nasdaq GlobeNewswire
-
Beam Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
03 Jan 2023 05:30:00 By Nasdaq GlobeNewswire
-
Beam Therapeutics Named to Boston Globe’s Top Places to Work List for 2022
02 Dec 2022 13:00:00 By Nasdaq GlobeNewswire